Penalty Amount
$19,200,000
Ford Motor Company agreed to a $19.2 million multistate settlement for falsely advertising the fuel economy of 2013–2014 C-Max hybrids and the payload capacity of 2011–2014 Super Duty pickup trucks. The settlement requires Ford to cease deceptive advertising practices and pay penalties to participating states.
Ford must pay $19.2 million in settlement funds and is enjoined from making false or misleading advertising claims about vehicle fuel economy and payload capacity.
In-house legal teams should review customer sales contracts, dealer agreements, and marketing/licensing agreements for clauses related to product specifications, advertising representations, and compliance with consumer protection laws. Specifically, examine representations and warranties regarding fuel economy and payload capacity, advertising and marketing compliance provisions, indemnification for false claims, and restitution mechanisms. Changes may include revising product specifications to align with advertised claims, implementing pre-approval processes for marketing materials, adding explicit accuracy guarantees, incorporating penalties for misrepresentations, and ensuring alignment with multistate settlement requirements, including potential corrective advertising obligations.
Entity
Ford Motor Company
Also known as: Ford
Industry
Automotive$376K
The California Privacy Protection Agency (CalPrivacy) settled with Ford Motor Company requiring the company to pay a $375,703 fine and change its practices. Ford violated the CCPA by requiring consumers to complete an email verification step before they could opt-out of the sale and sharing of their personal information collected through digital properties and connected vehicle services. In addition to the fine, Ford must provide easy methods to submit opt-out requests with minimal steps, audit its tracking technologies, and ensure compliance with opt-out preference signals including Global Privacy Control.
$376K
The California Privacy Protection Agency settled with Ford Motor Company for $375,703 after finding that Ford violated the CCPA by requiring email verification for opt-out requests, creating unnecessary friction. Ford must implement easier opt-out methods, conduct a website audit, and comply with global privacy controls.
On May 11, 2026, Connecticut Attorney General William Tong led a bipartisan coalition of 21 attorneys general in submitting a comment letter to the U.S. Food and Drug Administration (FDA) urging the agency to abandon draft guidance that would ease approvals for flavored e-cigarette products. The coalition argues the guidance ignores evidence that flavored e-cigarettes disproportionately drive youth addiction and that FDA has failed to enforce existing authorization requirements for e-cigarette products. The letter references past tobacco and e-cigarette enforcement actions, including the 1998 tobacco master settlement agreement and the 2022 $438.5 million settlement with JUUL Labs.
Connecticut’s legislature passed House Bill 5312, creating new civil enforcement mechanisms for deepfake digital sexual assault, including unauthorized dissemination of synthetically created intimate images and AI-generated child pornography. The bill establishes a private right of action for victims and empowers the Connecticut Attorney General to pursue civil injunctions and penalties against abusers and platforms hosting illegal content. This builds on prior Connecticut laws criminalizing unauthorized intimate image dissemination.
Connecticut Attorney General William Tong praised final passage of House Bill 5312, which creates new civil enforcement mechanisms for deepfake digital sexual assault. The legislation allows the AG to pursue civil injunctions and penalties against platforms that disseminate illegal synthetic intimate images, including AI-generated child pornography, and establishes a private right of action for victims. The bill builds on prior Connecticut laws criminalizing unauthorized dissemination of intimate images.
$300K
Connecticut Attorney General William Tong announced a settlement with international trade platform Made-in-China to cease all U.S. sales of unlawful 'research grade' GLP-1 weight loss drugs following an investigation into direct sales to consumers without prescriptions or medical oversight. The settlement prohibits the platform from hosting GLP-1 sales to U.S. customers, requires a monitoring system to remove non-compliant listings, and imposes a $300,000 penalty suspended after an initial $30,000 payment. Additional settlements were announced with Radiance Medspa and Advanced Medical Weight Loss over compounded non-FDA approved GLP-1 drugs.